UNRELATED DONOR REDUCED INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA

Myeloablative allogeneic hematopoietic cell transplantation (HCT) may cure patients with relapsed or refractory Hodgkin Lymphoma (HL), but is associated with a high treatment-related mortality (TRM). Reduced intensity and nonmyeloablative (RIC/NST) conditioning regimens aim to lower TRM. We analyzed...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Devetten, Marcel P., Hari, Parameswaran N., Carreras, Jeanette, Logan, Brent R., van Besien, Koen, Bredeson, Christopher N., Freytes, César O., Peter Gale, Robert, Gibson, John, Giralt, Sergio A., Goldstein, Steven C., Gupta, Vikas, Marks, David I., Maziarz, Richard T., Vose, Julie M., Lazarus, Hillard M., Anderlini, Paolo
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2009
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2929570/
https://ncbi.nlm.nih.gov/pubmed/19135949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2008.11.011
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi